Next, we asked if CDKN2A alteration could affect other immune components; therefore, we checked the correlation of CDKN2A alteration with the chemokine CCL4 and the chemokine receptor CCR6, which are known for their immunosuppressive roles against tumor development. This evidence concerns the gene CCR6 and neoplasm.